Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
 [1]
Current Assets:    
Cash and cash equivalents $ 22,739 $ 36,456
Restricted cash 2,351 13,069
Accounts receivable, net (net of allowance for credit losses of $59 and $105, respectively) 63,367 68,655
Inventories 71,115 66,628
Derivative instruments 14,038 4,973
Other current assets 5,919 9,340
Total current assets 179,529 199,121
Property and equipment, net 246,693 239,069
Other Assets:    
Right of use operating lease assets, net 24,433 18,937
Intangible assets, net 8,792 9,087
Goodwill 5,970 5,970
Other assets 5,993 6,137
Total other assets 45,188 40,131
Total Assets 471,410 478,321
Current Liabilities:    
Accounts payable 25,933 28,115
Accrued liabilities 15,328 26,556
Current portion – operating leases 3,914 3,849
Derivative instruments 8,396 6,732
Other current liabilities 5,115 12,765
Total current liabilities 58,686 78,017
Long-term debt, net 82,082 68,356
Operating leases, net of current portion 21,058 15,062
Other liabilities 8,791 8,797
Total Liabilities 170,617 170,232
Commitments and Contingencies (Note 6)
Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of June 30, 2023 and December 31, 2022; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of June 30, 2023 and December 31, 2022; liquidation preference of $18,075 as of June 30, 2023 1 1
Common stock, value 76 75
Additional paid-in capital 1,039,735 1,040,834
Accumulated other comprehensive income 1,822 1,822
Accumulated deficit (740,841) (734,643)
Total Stockholders’ Equity 300,793 308,089
Total Liabilities and Stockholders’ Equity 471,410 478,321
Non-voting common stock    
Stockholders’ Equity:    
Common stock, value
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2022.